Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients

被引:0
|
作者
Morehouse, Christopher [1 ]
Jiang, Liyan [2 ]
Huang, Jiagi [1 ]
Zhu, Wei [1 ]
Korolevich, Susana [1 ]
Ge, Xiaoxiao [3 ]
Lehmann, Kim [1 ]
Lui, Zheng [1 ]
Kiefer, Christine [1 ]
Czapiga, Meggan [1 ]
Su, Xinying [3 ]
Brohawn, Philip [1 ]
Gu, Yi [3 ]
Higgs, Brandon [1 ]
Yao, Yihong [1 ]
机构
[1] Medimmune, Gaithersburg, MD USA
[2] Shanghai Chest Hosp, Shanghai, Peoples R China
[3] Astrazeneca, Shanghai, Peoples R China
关键词
D O I
10.1158/1538-7445.AM2014-2377
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2377
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).
    Liu, Stephen, V
    Vanderwalde, Ari M.
    Mamdani, Hirva
    Raez, Luis E.
    Baca, Yasmine
    Xiu, Joanne
    Korn, Wolfgang Michael
    Nagasaka, Misako
    Pai, Sachin Gopalkrishna
    Socinski, Mark A.
    Nieva, Jorge J.
    Kim, Chul
    Wozniak, Antoinette J.
    Ikpeazu, Chukwuemeka
    Lopes, Gilberto
    Spira, Alexander, I
    Judd, Julia
    Kim, Edward S.
    Borghaei, Hossein
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] KRAS Mutations as Prognostic and Predictive Markers in Non-Small Cell Lung Cancer
    Martin, Petra
    Leighl, Natasha B.
    Tsao, Ming-Sound
    Shepherd, Frances A.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (05) : 530 - 542
  • [23] KRAS codon 12 mutations in Australian non-small cell lung cancer
    Fong, KM
    Zimmerman, PV
    Smith, PJ
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1998, 28 (02): : 184 - 189
  • [24] ONCOGENIC DRIVER MUTATIONS IN CHINESE NON-SMALL CELL LUNG CANCER (NSCLC)
    He, J.
    Yang, H.
    Deng, Q.
    He, P.
    Jiang, J.
    Zhao, M.
    Gu, X.
    Zheng, L.
    Pang, H.
    Zhou, J. X.
    ANNALS OF ONCOLOGY, 2012, 23 : 389 - 390
  • [25] Prevalence of KRAS`Mutations in Treatment-naive Non-small Cell Lung Cancer Patients in Hong Kong
    Tsang, S.
    Wong, C.
    Kan, J.
    Tsia, K.
    Ng, P. F.
    Loong, H.
    Ho, J. C.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S242 - S242
  • [26] Global research trends in immunotherapy for non-small cell lung cancer patients with KRAS mutations: a bibliometric analysis
    Shen, Hanyu
    Li, Chunxiao
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [27] Clinical characteristics, co-mutations and outcomes of advanced non-small cell lung cancer (NSCLC) patients with KRAS mutations.
    Muthiah, Arun
    Chudasama, Rani
    Olszewski, Adam J.
    Saiganesh, Harish
    Kurt, Habibe
    Mingrino, Jennifer
    Garcia-Moliner, Maria
    Azzoli, Christopher G.
    Khurshid, Humera
    Birnbaum, Ariel E.
    Khan, Hina
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] The impact of oncogenic driver mutations on neoadjuvant immunotherapy outcomes in patients with resectable non-small cell lung cancer
    Shen, Ziyun
    Teng, Meixin
    Han, Lu
    Bian, Dongliang
    Zhang, Jing
    Zhu, Xinsheng
    Qing, Yang
    Hu, Shiqi
    Chen, Yan
    Yao, Wangchao
    Yu, Huansha
    Zhang, Lele
    Zhang, Peng
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (12) : 4235 - 4247
  • [29] The impact of oncogenic driver mutations on neoadjuvant immunotherapy outcomes in patients with resectable non-small cell lung cancer
    Ziyun Shen
    Meixin Teng
    Lu Han
    Dongliang Bian
    Jing Zhang
    Xinsheng Zhu
    Yang Qing
    Shiqi Hu
    Yan Chen
    Wangchao Yao
    Huansha Yu
    Lele Zhang
    Peng Zhang
    Cancer Immunology, Immunotherapy, 2023, 72 : 4235 - 4247
  • [30] Frequency of KRAS and NRAS mutations in Bulgarian patients with colorectal cancer
    Bichev, S.
    Andonova, S.
    Hristova, L.
    Savov, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S232 - S232